Skip to main content
. 2021 Mar 12;21:48. doi: 10.1186/s12880-021-00571-x

Fig. 3.

Fig. 3

Workflow for identification of benign and malignant non-mass enhancement based on texture analysis. Processes in blue boxes were performed in MaZda